Trials / Conditions / Urethral Urothelial Carcinoma
Urethral Urothelial Carcinoma
5 registered clinical trials studyying Urethral Urothelial Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Partici NCT03617913 | Mayo Clinic | Phase 2 |
| Active Not Recruiting | Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot NCT02812420 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Completed | Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer NCT02437370 | University of California, Davis | Phase 1 |
| Active Not Recruiting | Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourin NCT02496208 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or C NCT02178241 | National Cancer Institute (NCI) | Phase 2 |